SAIL Fusion Gains FDA 510(k) for BowTie Sacroiliac Fusion

SAIL Fusion BowTie Sacroiliac Fusion System

SAIL Fusion received FDA clearance to market its novel BowTie Sacroiliac (SI) Fusion System. BowTie is reportedly the first SI fusion technology to be based on validated joint fusion principles established by the AO Foundation, and is now the only commercially available device that incorporates both intra‑articular and transfixing components.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us